Showing 1111-1120 of 5231 results for "".
Acne Scars: Optimizing Treatment with Devices and Combinations
https://practicaldermatology.com/topics/practice-management/acnescarsoptimizingtreatmentwithdevicesand-combinations/20542/Multiple factors affect the selection of a treatment for acne scars. Best outcomes are possible with a combination of approaches.What’s New in Topical Acne Treatment?
https://practicaldermatology.com/topics/acne-rosacea/whats-new-in-topical-acne-treatment/23277/Body Slimming: Exploring the Options
https://practicaldermatology.com/topics/practice-management/body-slimming-exploring-the-options/21112/Several experts share experiences and insights on the wide array of contouring devices.Notable Case Report: Intralesional Kenalog Injections for Chemotherapy-Induced Alopecia; Ask An Expert: Hair Loss
https://practicaldermatology.com/youngmd-connect/resident-resource-center/notable-case-report-intralesional-kenalog-injections-for-chemotherapy-induced-alopecia-ask-an-expert-hair-loss/21052/Should Children and Adolescents Be Screened for Primary Hyperhidrosis?
https://practicaldermatology.com/topics/rare-disease/should-children-and-adolescents-be-screened-for-primary-hyperhidrosis/39946/Should Children and Adolescents Be Screened for Primary Hyperhidrosis?
https://practicaldermatology.com/issues/novemberdecember-2025/should-children-and-adolescents-be-screened-for-primary-hyperhidrosis/48891/Primary hyperhidrosis (PH) is a chronic, often underreported and underdiagnosed condition without a cure. While it frequently runs in families, the exact etiology is unknown.News
https://practicaldermatology.com/topics/practice-management/news/21156/Resolution of Primary Erythromelalgia Following Ibuprofen; Fire Power
https://practicaldermatology.com/youngmd-connect/resident-resource-center/resolution-of-primary-erythromelalgia-following-ibuprofen-fire-power/20619/A Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into why